| Hans-Günter Meyer-Thompson | Legal
Negotiating better discounts for DAA therapy is critical to achieve HCV elimination by 2030.
Negotiating better discounts for DAA therapy is critical to achieve HCV elimination by 2030.
Dore GJ, Grebely J.
J Hepatol. 2017 Apr 11. pii: S0168-8278(17)30206-4. doi: 10.1016/j.jhep.2017.03.035.
http://www.journal-of-hepatology.eu/article/S0168-8278(17)30206-4/pdf